Literature DB >> 27527659

Total duration of antimicrobial therapy in veterans hospitalized with uncomplicated pneumonia: Results of a national medication utilization evaluation.

Karl J Madaras-Kelly1, Muriel Burk2,3, Christina Caplinger4, Jefferson G Bohan4, Melinda M Neuhauser3, Matthew Bidwell Goetz5, Rongping Zhang2, Francesca E Cunningham2,3.   

Abstract

OBJECTIVE: Practice guidelines recommend the shortest duration of antimicrobial therapy appropriate to treat uncomplicated pneumonia be prescribed to reduce the emergence of resistant pathogens. A national evaluation was conducted to assess the duration of therapy for pneumonia.
DESIGN: Retrospective medication utilization evaluation.
SETTING: Thirty Veterans Affairs medical centers. PATIENTS: Inpatients discharged with a diagnosis of pneumonia. MEASUREMENTS: A manual review of electronic medical records of inpatients discharged with uncomplicated community-acquired pneumonia (CAP) or healthcare-associated pneumonia (HCAP) was conducted. Appropriate CAP therapy duration was defined as at least 5 days, and up to 3 additional days beginning the first day the patient achieved clinical stability criteria; the appropriate HCAP therapy duration was defined as 8 days. The duration of antimicrobial therapy for intravenous (IV) and oral (PO) inpatient administration, PO therapy dispensed upon discharge, Clostridium difficile infection (CDI), hospital readmission, and death rates were measured.
RESULTS: Of 3881 pneumonia admissions, 1739 met inclusion criteria (CAP [n = 1195]; HCAP [n = 544]). Overall, 13.9% of patients (CAP [6.9%], HCAP [29.0%]) received therapy duration consistent with guideline recommendations. The median (interquartile range) days of therapy were 4 days (3-6 days), 1 day (0-3 days), and 6 days (4-8 days) for inpatient IV, inpatient PO, and outpatient PO antimicrobials, respectively. CDI was rare but more common in patients who received therapy duration consistent with guidelines. Therapy duration was not associated with the readmission or mortality rate.
CONCLUSIONS: Antimicrobials were commonly prescribed for a longer duration than guidelines recommend. The majority of excessive therapy was completed upon discharge, identifying the need for strategies to curtail unnecessary use postdischarge. Journal of Hospital Medicine 2015;11:832-839.
© 2015 Society of Hospital Medicine. © 2016 Society of Hospital Medicine.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27527659     DOI: 10.1002/jhm.2648

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  11 in total

1.  Duration of Antibiotic Use Among Adults With Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States.

Authors:  Sarah H Yi; Kelly M Hatfield; James Baggs; Lauri A Hicks; Arjun Srinivasan; Sujan Reddy; John A Jernigan
Journal:  Clin Infect Dis       Date:  2018-04-17       Impact factor: 9.079

2.  Decreases in Antimicrobial Use Associated With Multihospital Implementation of Electronic Antimicrobial Stewardship Tools.

Authors:  Christopher J Graber; Makoto M Jones; Matthew Bidwell Goetz; Karl Madaras-Kelly; Yue Zhang; Jorie M Butler; Charlene Weir; Ann F Chou; Sarah Y Youn; Matthew H Samore; Peter A Glassman
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

3.  In Data We Trust? Comparison of Electronic Versus Manual Abstraction of Antimicrobial Prescribing Quality Metrics for Hospitalized Veterans With Pneumonia.

Authors:  Barbara E Jones; Candace Haroldsen; Karl Madaras-Kelly; Matthew B Goetz; Jian Ying; Brian Sauer; Makoto M Jones; Molly Leecaster; Tom Greene; Scott K Fridkin; Melinda M Neuhauser; Matthew H Samore
Journal:  Med Care       Date:  2018-07       Impact factor: 2.983

4.  Linezolid to treat urinary tract infections caused by vancomycin-resistant Enterococcus.

Authors:  Benjamin Alan Pontefract; Suzette Amy Rovelsky; Karl Joseph Madaras-Kelly
Journal:  SAGE Open Med       Date:  2020-11-04

Review 5.  Antibiotic Overuse and Stewardship at Hospital Discharge: The Reducing Overuse of Antibiotics at Discharge Home Framework.

Authors:  Valerie M Vaughn; Adam L Hersh; Emily S Spivak
Journal:  Clin Infect Dis       Date:  2022-05-03       Impact factor: 20.999

6.  Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia.

Authors:  Caroline C Jozefczyk; W Justin Moore; Paul R Yarnold; Nathaniel J Rhodes; Karolina Harkabuz; Robert Maxwell; Sarah H Sutton; Christina Silkaitis; Chao Qi; Richard G Wunderink; Teresa R Zembower
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

7.  The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.

Authors:  Valerie M Vaughn; Tejal Gandhi; Anna Conlon; Vineet Chopra; Anurag N Malani; Scott A Flanders
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

8.  Antibiotic Overuse After Hospital Discharge: A Multi-hospital Cohort Study.

Authors:  Valerie M Vaughn; Tejal N Gandhi; Vineet Chopra; Lindsay A Petty; Daniel L Giesler; Anurag N Malani; Steven J Bernstein; Lama M Hsaiky; Jason M Pogue; Lisa Dumkow; David Ratz; Elizabeth S McLaughlin; Scott A Flanders
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

9.  Assessment of the Appropriateness of Antimicrobial Use in US Hospitals.

Authors:  Shelley S Magill; Erin O'Leary; Susan M Ray; Marion A Kainer; Christopher Evans; Wendy M Bamberg; Helen Johnston; Sarah J Janelle; Tolulope Oyewumi; Ruth Lynfield; Jean Rainbow; Linn Warnke; Joelle Nadle; Deborah L Thompson; Shamima Sharmin; Rebecca Pierce; Alexia Y Zhang; Valerie Ocampo; Meghan Maloney; Samantha Greissman; Lucy E Wilson; Ghinwa Dumyati; Jonathan R Edwards; Nora Chea; Melinda M Neuhauser
Journal:  JAMA Netw Open       Date:  2021-03-01

10.  Why we prescribe antibiotics for too long in the hospital setting: a systematic scoping review.

Authors:  Robin M E Janssen; Anke J M Oerlemans; Johannes G Van Der Hoeven; Jaap Ten Oever; Jeroen A Schouten; Marlies E J L Hulscher
Journal:  J Antimicrob Chemother       Date:  2022-07-28       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.